BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32593276)

  • 1. Rituximab treatment for lupus nephritis: A systematic review.
    Yuan Z; Xie Q; Wu X; Tan B; Zhang X
    Clin Invest Med; 2020 Jun; 43(2):E47-54. PubMed ID: 32593276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
    Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
    Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of an anti-CD20 monoclonal antibody, rituximab, for lupus nephritis: A meta-analysis.
    Teng S; Tian Y; Luo N; Zheng Q; Shao M; Li L
    Int J Rheum Dis; 2022 Feb; 25(2):101-109. PubMed ID: 34811947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.
    An Y; Zhou Y; Bi L; Liu B; Wang H; Lin J; Xu D; Wang M; Zhang J; Wang Y; An Y; Zhu P; Xie R; Zhang Z; Mei Y; Liu X; Deng X; Yao Z; Zhang Z; Wang Y; Xiao W; Shen H; Yang X; Xu H; Yu F; Wang G; Lu X; Li Y; Li Y; Zuo X; Li Y; Liu Y; Zhao Y; Guo J; Sun L; Zhao M; Li Z
    Clin Rheumatol; 2019 Apr; 38(4):1047-1054. PubMed ID: 30488367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide Versus Mycophenolate Versus Rituximab in Lupus Nephritis Remission Induction: A Historical Head-to-Head Comparative Study.
    Goswami RP; Sircar G; Sit H; Ghosh A; Ghosh P
    J Clin Rheumatol; 2019 Jan; 25(1):28-35. PubMed ID: 29561474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N; McEvoy M; Attia J; Ingsathit A; Ngamjanyaporn P; Thakkinstian A
    Medicine (Baltimore); 2010 Jul; 89(4):227-235. PubMed ID: 20616662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for lupus nephritis.
    Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
    Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis.
    Li K; Yu Y; Gao Y; Zhao F; Liang Z; Gao J
    Front Immunol; 2022; 13():859380. PubMed ID: 35444666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab use as induction therapy for lupus nephritis: a systematic review.
    Stolyar L; Lahita RG; Panush RS
    Lupus; 2020 Jul; 29(8):892-912. PubMed ID: 32486934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
    Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
    Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis.
    Gadakchi L; Hajialilo M; Nakhjavani MR; Abedi Azar S; Kolahi S; Gojazadeh M; Ebrahimi AA; Malek Mahdavi A; Noshad H; Khabbazi A
    Iran J Kidney Dis; 2018 Oct; 12(5):288-292. PubMed ID: 30367020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis.
    Li F; Cui W; Huang G; Tian Y; Zhang X; He W; Sun Q; Zhao X; Zhao Y; Li D; Liu X; Liu X
    Clin Exp Med; 2023 Nov; 23(7):3011-3018. PubMed ID: 37462818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.